Information displayed below is a subset of the entire knowledge base and may be incomplete intensionally or inadvertently. If you detect a serious error or want access to the complete knowledge base, please contact us.
Antithymocyte globulin (ATG) is a medication used to treat certain types of organ transplant rejection and aplastic anemia. It is a type of immunosuppressant, meaning it suppresses the body's immune system. ATG works by blocking the action of certain white blood cells, which are responsible for attacking transplanted organs.
Common side effects of ATG include fever, chills, nausea, vomiting, headache, muscle aches, and fatigue. Other more serious side effects include an increased risk of infection, anemia, and low platelet counts.
Brand names associated with ATG include Thymoglobulin, Atgam, and Thymoglobuline.
All of the following must be considered when interpreting clinical findings and are too extensive to be covered on this site: